Lupin gets US FDA nod for vitamin K injection with $52 million US market

Lupin has received US FDA approval for a prefilled vitamin K injection used to treat low blood clotting and vitamin K deficiency, with $52.3 million in annual US sales.

Leave a Reply

Your email address will not be published. Required fields are marked *